These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22873709)

  • 1. Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one skeleton.
    Aoyama A; Endo-Umeda K; Kishida K; Ohgane K; Noguchi-Yachide T; Aoyama H; Ishikawa M; Miyachi H; Makishima M; Hashimoto Y
    J Med Chem; 2012 Sep; 55(17):7360-77. PubMed ID: 22873709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators.
    Nomura S; Endo-Umeda K; Aoyama A; Makishima M; Hashimoto Y; Ishikawa M
    ACS Med Chem Lett; 2015 Aug; 6(8):902-7. PubMed ID: 26288691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand.
    Nishiyama Y; Nakamura M; Misawa T; Nakagomi M; Makishima M; Ishikawa M; Hashimoto Y
    Bioorg Med Chem; 2014 May; 22(9):2799-808. PubMed ID: 24702856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and In Vitro Evaluation of Novel Liver X Receptor Agonists Based on Naphthoquinone Derivatives.
    Nishioka T; Endo-Umeda K; Ito Y; Shimoda A; Takeuchi A; Tode C; Hirota Y; Osakabe N; Makishima M; Suhara Y
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling.
    Fradera X; Vu D; Nimz O; Skene R; Hosfield D; Wynands R; Cooke AJ; Haunsø A; King A; Bennett DJ; McGuire R; Uitdehaag JC
    J Mol Biol; 2010 May; 399(1):120-32. PubMed ID: 20382159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity.
    Chao EY; Caravella JA; Watson MA; Campobasso N; Ghisletti S; Billin AN; Galardi C; Wang P; Laffitte BA; Iannone MA; Goodwin BJ; Nichols JA; Parks DJ; Stewart E; Wiethe RW; Williams SP; Smallwood A; Pearce KH; Glass CK; Willson TM; Zuercher WJ; Collins JL
    J Med Chem; 2008 Sep; 51(18):5758-65. PubMed ID: 18800767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of the insulin-sensitizing effect of liver X receptor ligands.
    Commerford SR; Vargas L; Dorfman SE; Mitro N; Rocheford EC; Mak PA; Li X; Kennedy P; Mullarkey TL; Saez E
    Mol Endocrinol; 2007 Dec; 21(12):3002-12. PubMed ID: 17717069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
    Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
    Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
    Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
    J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor.
    Shenoy SD; Spencer TA; Mercer-Haines NA; Alipour M; Gargano MD; Runge-Morris M; Kocarek TA
    Drug Metab Dispos; 2004 Jan; 32(1):66-71. PubMed ID: 14709622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development.
    Dodo K; Aoyama A; Noguchi-Yachide T; Makishima M; Miyachi H; Hashimoto Y
    Bioorg Med Chem; 2008 Apr; 16(8):4272-85. PubMed ID: 18343126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
    Li X; Yeh V; Molteni V
    Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and optimization of a series of liver X receptor antagonists.
    Jiao X; Kopecky DJ; Fisher B; Piper DE; Labelle M; McKendry S; Harrison M; Jones S; Jaen J; Shiau AK; Escaron P; Danao J; Chai A; Coward P; Kayser F
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5966-70. PubMed ID: 22901900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
    Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
    Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists.
    Matsui Y; Yamaguchi T; Yamazaki T; Yoshida M; Arai M; Terasaka N; Honzumi S; Wakabayashi K; Hayashi S; Nakai D; Hanzawa H; Tamaki K
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3914-20. PubMed ID: 26238323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and SAR of potent LXR agonists containing an indole pharmacophore.
    Washburn DG; Hoang TH; Campobasso N; Smallwood A; Parks DJ; Webb CL; Frank KA; Nord M; Duraiswami C; Evans C; Jaye M; Thompson SK
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1097-100. PubMed ID: 19167885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver X receptor is a regulator of orphan nuclear receptor NOR-1 gene transcription in adipocytes.
    Kumar N; Wang H; Liu D; Collins S
    Int J Obes (Lond); 2009 May; 33(5):519-24. PubMed ID: 19238156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Synthesis of a Novel Series of Liver X Receptor Antagonists.
    Nian S; Gan X; Tan X; Yu Z; Wang P; Chen X; Wang G
    Chem Pharm Bull (Tokyo); 2015; 63(8):628-35. PubMed ID: 26062802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.
    Hu B; Quinet E; Unwalla R; Collini M; Jetter J; Dooley R; Andraka D; Nogle L; Savio D; Halpern A; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):54-9. PubMed ID: 18023179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice.
    Han SI; Komatsu Y; Murayama A; Steffensen KR; Nakagawa Y; Nakajima Y; Suzuki M; Oie S; Parini P; Vedin LL; Kishimoto H; Shimano H; Gustafsson JÅ; Yanagisawa J
    Hepatology; 2014 May; 59(5):1791-802. PubMed ID: 24277692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.